stethoscopeGLP-1 & Metabolic Medicine
Evidence-based coverage of GLP-1 drugs like Ozempic and Wegovy, cholesterol treatments, diabetes and weight-loss medicine, with the safety questions patients actually ask.
Tirzepatide and Ixekizumab Combo Shows 1-Year Trial Results
Statins May Cut Dementia Risk by Up to 15 Percent, Study Finds
University of Oulu researchers tracking a 1966 birth cohort found people who drank more coffee carried less total and visceral fat, more skeletal muscle, and a distinct hormone profile, but the study is observational and proves nothing about cause
A new study found most young adults, average age 23, already met the definition of cardiovascular-kidney-metabolic syndrome, and the ones furthest along had early signs of artery injury
Dutch researchers say low-dose digoxin cut heart-failure hospital admissions by about a quarter, but the headline trial missed its own main target
The most common kidney tumor rewires how it burns fuel, and that rewiring is what lets it dodge treatment. A 2025 review lays out the mechanism.
A study of 236 families found the relatives caring for people with Crohn's and colitis are quietly worn down, and the clock is the heaviest part.
Study links microplastics to acute heart attacks in 84% of patients
Danes on GLP-1 drugs took far fewer month-plus sick-leave spells. The salary math is real, but it leaves out the price of the drugs.
Novo Nordisk sues Eli Lilly over allegedly false GLP-1 weight-loss ads
When GLP-1 Users Swap Meals for Shakes, Health Risks Linger
New $100M Trial Pairs Lifestyle Changes with Metabolic Drugs for Dementia
Doctors flag a hidden GLP-1 risk for people with ALS
